These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23153292)
1. Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments. Nguyen L; Fifis T; Malcontenti-Wilson C; Chan LS; Costa PN; Nikfarjam M; Muralidharan V; Christophi C BMC Cancer; 2012 Nov; 12():522. PubMed ID: 23153292 [TBL] [Abstract][Full Text] [Related]
2. Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor. Fifis T; Nguyen L; Malcontenti-Wilson C; Chan LS; Nunes Costa PL; Daruwalla J; Nikfarjam M; Muralidharan V; Waltham M; Thompson EW; Christophi C Cancer Med; 2013 Oct; 2(5):595-610. PubMed ID: 24403226 [TBL] [Abstract][Full Text] [Related]
3. Vascular disruptive agent OXi4503 and anti-angiogenic agent Sunitinib combination treatment prolong survival of mice with CRC liver metastasis. Nguyen L; Fifis T; Christophi C BMC Cancer; 2016 Jul; 16():533. PubMed ID: 27460820 [TBL] [Abstract][Full Text] [Related]
4. Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model. Malcontenti-Wilson C; Chan L; Nikfarjam M; Muralidharan V; Christophi C J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e96-e104. PubMed ID: 17559382 [TBL] [Abstract][Full Text] [Related]
5. Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis. Chan LS; Malcontenti-Wilson C; Muralidharan V; Christophi C Anticancer Res; 2007; 27(4B):2317-23. PubMed ID: 17695520 [TBL] [Abstract][Full Text] [Related]
6. Alterations in vascular architecture and permeability following OXi4503 treatment. Chan LS; Malcontenti-Wilson C; Muralidharan V; Christophi C Anticancer Drugs; 2008 Jan; 19(1):17-22. PubMed ID: 18043126 [TBL] [Abstract][Full Text] [Related]
7. Combretastatin family member OXI4503 induces tumor vascular collapse through the induction of endothelial apoptosis. Sheng Y; Hua J; Pinney KG; Garner CM; Kane RR; Prezioso JA; Chaplin DJ; Edvardsen K Int J Cancer; 2004 Sep; 111(4):604-10. PubMed ID: 15239140 [TBL] [Abstract][Full Text] [Related]
8. Styrene maleic acid copolymer-pirarubicin induces tumor-selective oxidative stress and decreases tumor hypoxia as possible treatment of colorectal cancer liver metastases. Daruwalla J; Greish K; Malcontenti-Wilson C; Muralidharan V; Maeda H; Christophi C Surgery; 2015 Jul; 158(1):236-47. PubMed ID: 25999256 [TBL] [Abstract][Full Text] [Related]
9. Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503. Rice L; Pampo C; Lepler S; Rojiani AM; Siemann DW Microvasc Res; 2011 Jan; 81(1):44-51. PubMed ID: 20974154 [TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Zhang Q; Bai X; Chen W; Ma T; Hu Q; Liang C; Xie S; Chen C; Hu L; Xu S; Liang T Carcinogenesis; 2013 May; 34(5):962-73. PubMed ID: 23358852 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
12. Fatty Acids and a High-Fat Diet Induce Epithelial-Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells. Kwapisz O; Górka J; Korlatowicz A; Kotlinowski J; Waligórska A; Marona P; Pydyn N; Dobrucki JW; Jura J; Miekus K Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525359 [TBL] [Abstract][Full Text] [Related]
13. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition. Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702 [TBL] [Abstract][Full Text] [Related]
14. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer. Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751 [TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells. Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory action of pristimerin on hypoxia‑mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells. Zuo J; Guo Y; Peng X; Tang Y; Zhang X; He P; Li S; Wa Q; Li J; Huang S; Xu D Oncol Rep; 2015 Mar; 33(3):1388-94. PubMed ID: 25571882 [TBL] [Abstract][Full Text] [Related]
17. Oxi4503, a novel vascular targeting agent: effects on blood flow and antitumor activity in comparison to combretastatin A-4 phosphate. Hua J; Sheng Y; Pinney KG; Garner CM; Kane RR; Prezioso JA; Pettit GR; Chaplin DJ; Edvardsen K Anticancer Res; 2003; 23(2B):1433-40. PubMed ID: 12820406 [TBL] [Abstract][Full Text] [Related]
18. Leukemia regression by vascular disruption and antiangiogenic therapy. Madlambayan GJ; Meacham AM; Hosaka K; Mir S; Jorgensen M; Scott EW; Siemann DW; Cogle CR Blood; 2010 Sep; 116(9):1539-47. PubMed ID: 20472832 [TBL] [Abstract][Full Text] [Related]
19. Hypoxia-inducible factor 1α-induced epithelial-mesenchymal transition of endometrial epithelial cells may contribute to the development of endometriosis. Xiong Y; Liu Y; Xiong W; Zhang L; Liu H; Du Y; Li N Hum Reprod; 2016 Jun; 31(6):1327-38. PubMed ID: 27094478 [TBL] [Abstract][Full Text] [Related]
20. Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuit. Mak KK; Wu AT; Lee WH; Chang TC; Chiou JF; Wang LS; Wu CH; Huang CY; Shieh YS; Chao TY; Ho CT; Yen GC; Yeh CT Mol Nutr Food Res; 2013 Jul; 57(7):1123-34. PubMed ID: 23504987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]